- Home
- IFRX vs APT Comparison
IFRX vs APT Comparison
Compare IFRX & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- APT
- Stock Information
- Founded
- IFRX 2007
- APT 1983
- Country
- IFRX Germany
- APT Canada
- Employees
- IFRX N/A
- APT N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- IFRX Health Care
- APT
- Exchange
- IFRX Nasdaq
- APT Nasdaq
- Market Cap
- IFRX 56.4M
- APT 50.5M
- IPO Year
- IFRX 2017
- APT 1995
- Fundamental
- Price
- IFRX $0.79
- APT $4.75
- Analyst Decision
- IFRX Strong Buy
- APT
- Analyst Count
- IFRX 4
- APT 0
- Target Price
- IFRX $7.75
- APT N/A
- AVG Volume (30 Days)
- IFRX 282.5K
- APT 23.9K
- Earning Date
- IFRX 08-07-2025
- APT 08-06-2025
- Dividend Yield
- IFRX N/A
- APT N/A
- EPS Growth
- IFRX N/A
- APT 2.28
- EPS
- IFRX N/A
- APT 0.36
- Revenue
- IFRX $140,242.00
- APT $58,180,000.00
- Revenue This Year
- IFRX N/A
- APT N/A
- Revenue Next Year
- IFRX $6,309.47
- APT N/A
- P/E Ratio
- IFRX N/A
- APT $13.17
- Revenue Growth
- IFRX 30.90
- APT N/A
- 52 Week Low
- IFRX $0.71
- APT $4.06
- 52 Week High
- IFRX $2.82
- APT $6.44
- Technical
- Relative Strength Index (RSI)
- IFRX 37.43
- APT 53.37
- Support Level
- IFRX $0.78
- APT $4.68
- Resistance Level
- IFRX $0.83
- APT $4.95
- Average True Range (ATR)
- IFRX 0.04
- APT 0.17
- MACD
- IFRX 0.03
- APT 0.01
- Stochastic Oscillator
- IFRX 52.00
- APT 48.84
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.